Invidious
Log in
Society of Pharmaceutical Sciences and Research
Subscribe | 24K
 RSS

Welcome to the Official YouTube Channel of the Society of Pharmaceutical Sciences and Research (SPSR)

πŸ”΄ SPSR is a leading platform committed to advancing pharmaceutical research, innovation, & education. We bring together scientists, researchers, educators, & students from around the world through:

πŸ“ Expert-led webinars & scientific talks
πŸ“ Insights into emerging pharma trends
πŸ“ Awareness on public health challenges
πŸ“ Tutorials on pharmaceutical sciences & research methodology
πŸ“Events, conferences, & journal activities

πŸ”” Subscribe now & turn on notifications for regular updates on pharmaceutical innovations, research breakthroughs, & educational resources.

πŸ”΄ Become a Member of SPSR - Elevate Your Professional Journey! For more details visit spsrpharma.org/become-a-member

βœ… Join our mission to promote quality pharmaceutical science & make a real-world impact.

πŸ“š SPSR official publications: IJPSR (www.ijpsr.com) and IJP (www.ijpjournal.com)

☎️: +91-9452226352 (Whatsapp)

View channel on YouTube
Switch Invidious Instance
Videos
Shorts
Livestreams
Playlists
Posts

Society of Pharmaceutical Sciences and Research

πŸ”Ί Smart Fertility Tracking Is Quietly Changing Women’s Healthcare πŸ”Ί

A few years ago…

Most women tracked their cycles on calendars.
Some relied on guesswork.
Many simply ignored symptoms because β€œit’s normal.”

Today?
AI-powered apps, smart rings, wearable sensors and hormone tracking platforms are turning reproductive healthcare into personalized healthcare.

And India is becoming one of the fastest-growing FemTech markets.

The shift is massive.

πŸ“± Period tracking is evolving into predictive healthcare
⌚ Wearables can now help monitor ovulation patterns
🧠 AI is helping women understand hormonal trends
πŸ₯ Telehealth is making fertility support more accessible

But this isn’t just about technology.
It’s about solving real Indian problems.

Because millions of women still struggle with:

β€’ delayed diagnosis of PCOS
β€’ fertility anxiety
β€’ lack of reproductive awareness
β€’ social stigma around infertility
β€’ limited access to specialists

And here’s what makes this even more interesting…

India’s FemTech market was valued at nearly $1.48 billion in 2025 and is projected to grow rapidly in the coming years.

Women’s healthcare is finally moving:

➑️ from reactive to preventive
➑️ from generic to personalized
➑️ from silence to data-driven decisions

The real opportunity?

Making these tools affordable, culturally relevant, and accessible beyond metro cities.

Because the future of reproductive healthcare may not begin in a clinic.
It may begin on a smartphone.

If you believe FemTech and smart healthcare deserve more visibility in India, share this ♻️ post to keep the conversation growing.

Because awareness is often the first step toward better healthcare.

βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–
Elevate your professional journey with Society of Pharmaceutical Sciences and Research (SPSR) β€” become a member today.

πŸ”— spsrpharma.org/become-a-member
βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–

2 weeks ago | [YT] | 3

View 0 replies

Society of Pharmaceutical Sciences and Research

What If Pain Relief Didn’t Need a Pill? The Quiet Rise of Transdermal Drug Delivery (TDDS)

We’ve relied on oral and injectable drugs for decades.
But they come with a trade-off:

β–ͺ️ Fluctuating drug levels
β–ͺ️ First-pass liver metabolism
β–ͺ️ Systemic side effects like sedation & GI issues

Now think about skeletal muscle relaxants like tizanidine and baclofen…

For many patients especially the elderly or those with comorbidities, these side effects aren’t minor inconveniences.

They directly affect quality of life, adherence, and outcomes.

βœ”οΈTransdermal Drug Delivery Systems (TDDS)βœ”οΈ
Instead of going through the gut and liver, TDDS delivers drugs through the skin slowly, steadily, and more precisely.

A simple patch…
But a powerful shift in how we think about therapy.

Why TDDS is gaining attention

β–ͺ️ Bypasses first-pass metabolism β†’ improved bioavailability
β–ͺ️ Sustained drug release β†’ stable plasma levels
β–ͺ️ Reduced systemic side effects β†’ better tolerability
β–ͺ️ Improved patient compliance β†’ especially in chronic therapy

What’s happening behind the patch?

This isn’t just a sticker, it’s advanced pharmaceutical engineering:

β–ͺ️ Matrix & Reservoir systems controlling drug release
β–ͺ️ Novel carriers (Aspasomes, Niosomes) enhancing skin penetration
β–ͺ️ Penetration enhancers + polymer matrices overcoming the skin barrier

Early preclinical and limited clinical data suggest:

βœ”οΈ Consistent therapeutic effect
βœ”οΈ Better adherence
βœ”οΈ Patient-friendly administration

But let’s stay realistic

β–ͺ️ Skin permeability still limits drug selection
β–ͺ️ Not all molecules are TDDS-friendly
β–ͺ️ Large-scale clinical trials are still needed

πŸ”Ž The Bigger Shift
TDDS is not just about avoiding pills.

It’s about:
➑️ Designing smarter delivery systems
➑️ Reducing treatment burden
➑️ Making therapies more human-centric

Want the full picture?
The complete article explores:

β–ͺ️ Advanced formulation strategies
β–ͺ️ Novel delivery carriers
β–ͺ️ Emerging evidence on efficacy & compliance

πŸ‘‰ If you’re in pharma, research, or healthcare, this is worth a deeper read. πŸ‘‡

ijpsr.com/bft-article/a-review-article-on-transede…

βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–
Elevate your professional journey with Society of Pharmaceutical Sciences and Research (SPSR) β€” become a member today.

πŸ”— spsrpharma.org/become-a-member
βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–

2 weeks ago | [YT] | 4

View 0 replies

Society of Pharmaceutical Sciences and Research

MAY 2026: CDSCO APPROVES TRASTUZUMAB
"A TURNING POINT IN CANCER CARE"

Cancer treatment in India is evolving and this approval marks a shift from broad chemotherapy to targeted precision medicine
.
The Central Drugs Standard Control Organisation (CDSCO) has approved trastuzumab-based therapy, a breakthrough for HER2-positive breast and metastatic gastric cancers.

Here’s why this matters
India is witnessing a sharp rise in cancer burden:

β€’ Breast cancer is now the #1 cancer among Indian women
β€’ Cases have increased by ~40% over the past 25 years
β€’ HER2-positive cancers tend to be more aggressive, but also more targetable

And that’s where trastuzumab changes the game:

β€’ Specifically targets HER2 receptors driving tumor growth
β€’ Improves survival outcomes when combined with standard therapy
β€’ Brings global-standard targeted care closer to Indian patients

This isn’t just another approval.
It’s a reflection of how oncology in India is moving toward biology-driven treatment, not just symptom control.

From hospital corridors to research labs
this is what progress looks like when science meets real patient need.

Share ♻️ this to spread awareness about advances in cancer care in India.
βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–
Elevate your professional journey with Society of Pharmaceutical Sciences and Research - SPSR β€” become a member today.

πŸ”— spsrpharma.org/become-a-member
βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–

3 weeks ago | [YT] | 10

View 0 replies

Society of Pharmaceutical Sciences and Research

April FDA New Drug Approvals 2026:

A new name just entered the obesity treatment conversation: orforglipron (Foundayo). And it’s worth paying attention.

Obesity isn’t just about weight.
It’s about risk.

Risk of diabetes.
Risk of heart disease.
Risk of reduced quality of life.

Globally and especially in India, obesity is rising at an alarming pace.
Sedentary lifestyles. Ultra-processed diets. Chronic stress.

We’re not just dealing with a lifestyle issue anymore.
We’re dealing with a chronic disease.

Now, the update πŸ‘‡

The U.S. Food and Drug Administration has recently approved orforglipron (Foundayo) for:

βœ”οΈ Reducing excess body weight
βœ”οΈ Maintaining long-term weight reduction
βœ”οΈ Adults with obesity
βœ”οΈ Adults with overweight + at least one weight-related comorbidity

But here’s the key:

It’s approved in combination with

β†’ Reduced-calorie diet
β†’ Increased physical activity

Why this matters:

β€’ A new oral option in the weight management space
β€’ Expands accessibility beyond injectables
β€’ Reinforces obesity as a treatable medical condition, not just willpower

But let’s be clear

No drug replaces discipline.
No pill replaces lifestyle.

Medication supports.
Habits sustain.

The real shift is this:

We’re finally moving from blame β†’ biology
From stigma β†’ science

Conclusion:

Approvals like orforglipron are not just about a new drug.
They signal a larger transformation in how we understand and treat obesity.

And that’s long overdue.

If you’re in healthcare, research, or public health, this is your cue to stay updated.
Because the future of obesity management is evolving… fast.

Share ♻️ this with your network to spread awareness.
Let’s move the conversation from myths to medicine.

βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–
Elevate your professional journey with Society of Pharmaceutical Sciences and Research (SPSR) β€” become a member today.

πŸ”— spsrpharma.org/become-a-member
βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–

1 month ago | [YT] | 0

View 0 replies

Society of Pharmaceutical Sciences and Research

You might be just 1️⃣ mistake away from rejection…
(and it’s NOT your research)

Most researchers don’t realize this

Before submitting, ask yourself:
Have I checked if this journal even publishes work like mine?

Here’s the part no one tells you…

Editors often decide in minutes whether your paper fits.
Not based on quality firstβ€”
but on fit.

Truth:
It’s not your paper that failsβ€”
it’s your journal choice.

One line to remember:
Right Journal. Faster Acceptance.

Here is a simple system you should see before your next submission.

⏳ Because 10 minutes of checking today…
can save you months of rejection tomorrow.

πŸ“© Want the exact checklist to use?
Reply β€œCHECKLIST” on the link given and I’ll send it to you.πŸ‘‡πŸ»

πŸ”— tinyurl.com/42776nmd

1 month ago | [YT] | 4

View 0 replies

Society of Pharmaceutical Sciences and Research

1 in 68 children in India has autism.
But most people still don’t see it.

April 2 is World Autism Awareness Day
But awareness alone isn’t enough anymore.

Because in India:
β€’ Millions remain undiagnosed
β€’ Parents mistake signs for β€œnormal delay”
β€’ Support often comes too late

Autism doesn’t start loud.
β–ͺ️ It starts quietly
β–ͺ️ No eye contact.
β–ͺ️ Delayed speech.
β–ͺ️ Social withdrawal.
And often… ignored.

Here’s the truth we need to accept:

Autism is not a disease.
It’s a different way of experiencing the world.

And with early support
lives can completely transform.

What we must do (starting today):
βœ”οΈ Talk about early signs
βœ”οΈ Educate parents (especially in local communities)
βœ”οΈ Stop labeling, start understanding
βœ”οΈ Promote inclusion in schools & workplaces

Because awareness is easy.
But acceptance + action? That’s impact.

If this made you think
share it with your network.

Someone might recognize the signs today
and change a child’s future tomorrow.

βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–
Elevate your professional journey with Society of Pharmaceutical Sciences and Research (SPSR) β€” become a member today.

πŸ”— spsrpharma.org/become-a-member
βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–

1 month ago | [YT] | 3

View 0 replies

Society of Pharmaceutical Sciences and Research

Your Brain Might Just Be Out of Balance.
Read that again.

Because insomnia isn’t always about stress or screen time.
Sometimes, it’s about neurotransmitters, not doing their job.

And this is where things get interesting:
What if a Leaf Could Influence Your Sleep Cycle?

Not a pill.
Not melatonin.
But compounds from Morus alba (mulberry leaves).

Mulberry leaves are loaded with flavonoids like:

β–ͺ️ Quercetin
β–ͺ️ Rutin
β–ͺ️ Kaempferol
These don’t just β€œrelax” you.

They talk to your brain chemistry:
Sounds simple… but the science isn’t.

βœ”οΈ Boost GABA β†’ the signal that tells your brain to slow down
βœ”οΈ Modulate Serotonin β†’ the system that controls your sleep-wake rhythm
βœ”οΈ Help you fall asleep faster (reduced sleep latency)

This Isn’t Just β€œHerbal”, It’s Neuroactive

Most people think:

🌿 Herbal = Mild
πŸ’Š Drugs = Strong

But here’s the shift:

β–ͺ️ Mulberry flavonoids may directly influence GABA-A and 5-HT receptors
β–ͺ️ That’s the same pathway many sleep medications target

Let that sink in.

What Research Is Pointing Toward

β–ͺ️ Better sleep quality
β–ͺ️ Improved relaxation response
β–ͺ️ A potential natural alternative to synthetic sleep aids

But let’s stay grounded:

β–ͺ️ Clinical validation is still needed
β–ͺ️ Dosage & long-term effects require more research

The Future of Sleep Might Be Plant-Based

We’re moving from:

β–ͺ️ Symptom suppression
β–ͺ️ Neurochemical alignment

And mulberry leaves might be part of that transition.

If This Made You Think…
Don’t just scroll past.

β–ͺ️ Read the full research
β–ͺ️ Share this with your network
β–ͺ️ Start a conversation on science-backed natural sleep solutions

Because better sleep isn’t always about doing more…
Sometimes, it’s about working with your biology

πŸ”— ijpsr.com/bft-article/sleep-inducing-effects-of-mu…

βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–
Elevate your professional journey with Society of Pharmaceutical Sciences and Research (SPSR) β€” become a member today.

πŸ”— spsrpharma.org/become-a-member
βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–

1 month ago | [YT] | 4

View 0 replies

Society of Pharmaceutical Sciences and Research

March 2026 FDA New Drug Approval Highlights: A Breakthrough for Rare Diseases

β€’ New drug approvals bringing hope to underserved conditions
β€’ Focus shifting toward genetic and orphan disorders
β€’ Precision medicine is no longer the future, it’s NOW

One of the most powerful approvals this month: Avlayah for Hunter syndrome (MPS II).

Hunter syndrome is a rare, inherited disorder where the body lacks a critical enzyme, causing harmful substances to build up in tissues.

This leads to progressive damage affecting development, organs, mobility, and quality of life, primarily in young boys.

For years, treatment options have been limited. Families have been fighting a silent battle.

Now, Avlayah changes the conversation.

πŸ”Ή A targeted approach addressing the underlying cause
πŸ”Ή Potential to improve disease progression
πŸ”Ή A major step forward in rare disease therapeutics


This is more than just another approval.
It’s hope for patients, caregivers, and the entire rare disease community.

The bigger picture?
We are entering an era where even the rarest conditions are no longer ignored. Innovation is reaching those who need it the most.

Every approval like this reminds us, science is not just advancing, it’s becoming more inclusive. And that’s where real impact begins.

If you’re in healthcare, pharma, or research, this is worth your attention.

♻️ Share this with your network to spread awareness about Hunter syndrome and the breakthroughs shaping its future.

βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–
Elevate your professional journey with Society of Pharmaceutical Sciences and Research - SPSR β€” become a member today.

πŸ”— spsrpharma.org/become-a-member
βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–

1 month ago | [YT] | 5

View 0 replies

Society of Pharmaceutical Sciences and Research

Diabetes isn’t just about sugar. It’s about missed natural solutions.

India’s traditional medicinal plants are targeting diabetes from multiple pathways, not just one?

Not theory.
Science-backed phytoconstituents. Proven mechanisms.

Here’s what most people overlook:

🌿 Gymnema (Gurmar) β†’ Literally called β€œsugar destroyer”
Blocks sugar absorption + supports pancreatic cells

🌿 Bitter Gourd (Karela) β†’ Nature’s insulin mimic
Improves glucose uptake + reduces liver glucose output

🌿 Fenugreek (Methi) β†’ Simple kitchen seed, powerful effect
Boosts insulin secretion + controls post-meal spikes

🌿 Jamun Seed β†’ Underrated but effective
Slows starch-to-glucose conversion + protects Ξ²-cells

🌿 Salacia β†’ Rare but potent
Strong Ξ±-glucosidase inhibitor β†’ controls postprandial sugar

🌿 Pterocarpus marsupium β†’ Regenerative potential
Supports Ξ²-cell restoration + antioxidant defense

🌿 Giloy (Tinospora) β†’ Beyond immunity
Improves glucose metabolism + reduces oxidative stress

🌿 Turmeric (Curcumin) β†’ More than anti-inflammatory
Enhances insulin sensitivity + protects pancreatic cells

🌿 Daruharidra (Berberis) β†’ The metabolic regulator
Activates AMPK pathway (metformin-like action)

Here’s the real insight:

These plants don’t work in isolation.
They:

βœ” Improve insulin function
βœ” Reduce glucose absorption
βœ” Protect pancreatic cells
βœ” Fight oxidative stress

A true multi-target approach to diabetes management

But here’s the gap:

Most people know the names…
Very few understand the mechanisms.

If you’re in pharma, research, or healthcare
this is where traditional knowledge meets modern science.

Dive deeper into the phytoconstituents & mechanisms behind these plants.
Understand how they actually work, not just that they work.

If this added value to your knowledge:
Share ♻️ it with your network.
Someone in your circle needs to see this.

πŸ”— ijpsr.com/bft-article/indian-medicinal-plants-with…

βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–
Elevate your professional journey with Society of Pharmaceutical Sciences and Research (SPSR) β€” become a member today.

πŸ”— spsrpharma.org/become-a-member
βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–

1 month ago | [YT] | 4

View 0 replies

Society of Pharmaceutical Sciences and Research

Most pharmacy graduates learn about medicines.

But very few learn about quality systems behind those medicines.

And that’s the real difference between
a degree holder and a future-ready pharmacist.

Because in pharmacy…

Quality is not optional.
Quality is responsibility.

That’s exactly what we explored in the 99th Society of Pharmaceutical Sciences and Research (SPSR) Webinar.

Theme:
Empowering Pharma Education with QCI: A Strategic Shift Towards Excellence.

We were honored to host Dr. NEELESH MALVIYA, Professor and Principal at Smriti College of Pharmaceutical Education Indore, Indore, who delivered an incredibly insightful session.

His message was simple but powerful:

Pharma education must move beyond knowledge
towards quality-driven competence.

Through the lens of the Quality Council of India(QCI), the session highlighted how integrating quality frameworks into academics, research, and training can reshape pharmaceutical education in India.

But why does this matter?
Because pharmacists are the custodians of medicine quality.

When pharmacy institutions align with QCI standards:

β€’ Education becomes outcome-focused
β€’ Research meets global benchmarks
β€’ Training becomes industry-relevant
β€’ And pharmacists become globally competent professionals

Dr. Malviya also emphasized that:

β€’ Teachers drive quality through mentorship and structured learning.
β€’ Institutions build credibility through accreditation and standards.
β€’ Students gain stronger employability, innovation skills, and global exposure.

Here’s the reality:

The future pharmacist will not just dispense medicines.
They will defend quality, safety, and trust.

And frameworks promoted by the Quality Council of India are helping make that shift possible.

If you care about the future of pharmaceutical education,
this conversation is worth watching.

▢️ Watch the complete webinar to explore how QCI can transform pharma education.

πŸ”— youtube.com/live/_4DDBqzBMEQ?feature=share

And if you believe quality should define the next generation of pharmacists,
share this with your network so more educators, students, and professionals can join the conversation.

βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–
Elevate your professional journey with Society of Pharmaceutical Sciences and Research - SPSR β€” become a member today.

spsrpharma.org/become-a-member
βž– βž– βž– βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž– βž–βž– βž–

2 months ago | [YT] | 12

View 1 reply

Load more